NIH-funded research NIH-funded research

Immune responses to malaria, HIV, and COVID-19 vaccines in diverse populations

Official title: Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization

Funded at Seattle Children's Hospital · NIH-11361542 · Data updated 2026-11-12

A large NIH effort is studying how our immune system reacts to HIV, malaria, and COVID-19 vaccines to help design better vaccines for everyone.

More SARS-CoV-2 research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSeattle Children's Hospital
NIH-funded
Lab location1 site (Seattle, United States)
Project startJuly 19, 2017
Project endApril 30, 2027
Funding year2026
Award (this year)$2,100,000
NIH project number5U19AI128914-11
Project IDNIH-11361542 on NIH RePORTER

Who could benefit from this research

Could help

Individuals affected by HIV/AIDS, malaria, or COVID-19, and diverse populations who may contribute samples or participate in related studies.

Less likely to help

People who do not have exposure to these infections or who are not eligible for related studies may not directly benefit.

What this research studies

This project looks at how people’s immune systems respond to infections and vaccines for three major diseases: HIV/AIDS, malaria, and COVID-19. Researchers will profile different immune responses across diverse populations to identify patterns linked to protection after vaccination or infection. The work involves complex biological analyses and collaboration across experts to connect immune profiles with vaccine efficacy. The goal is to uncover insights that can guide more effective vaccines and therapies for these diseases.

Why it matters

Potential benefit: If successful, findings could inform the design of more protective vaccines and therapies for HIV, malaria, and COVID-19, benefiting patients worldwide.

How similar studies have gone: Prior work has shown that identifying immune signatures can correlate with vaccine protection, supporting the potential for impactful discoveries.

Where this research is happening

  • Seattle Children's Hospital
    Seattle, United States
    Active

Researchers

  • Principal investigator: Stuart, Kenneth D — Seattle Children's Hospital
  • Study coordinator: Stuart, Kenneth D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.